RLAY Competitors & Alternatives
Compare Relay Therapeutics Inc with similar stocks in the same industry
Biotechnology
RLAY
Main Stock$17.14
Tradestie Score
59
Market Cap
$917.23M
Revenue Growth
-0.6%
Analyst Upside
+44.8%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$17.25
|
$3.68B | - | 53 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$109.06
|
$3.67B | - | 55 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$8.55
|
$3.59B | 12.4 | 59 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$22.28
|
$3.58B | 9.8 | 59 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$256.37
|
$3.49B | 34.3 | 67 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.04
|
$3.40B | - | 53 | Compare |
|
QURE
uniQure N.V.
|
$46.08
|
$3.39B | - | 57 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$49.01
|
$3.33B | - | 61 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$29.96
|
$3.31B | - | 50 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 49 | Compare |
More RLAY Analysis
Data updated: Jun 22, 2026 | Industry: Biotechnology (SIC 2836)
218 stocks in this industry